Neoadjuvant Cemiplimab Plus Imiquimod in Cutaneous Basal Cell Carcinoma.

Category Primary study
Registry of TrialsClinical Trials Information System
Year 2025
This article has no abstract
Epistemonikos ID: 028fe547c88449c996f0a0b4a97f2746971f1b29
First added on: Jan 17, 2026